By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Anavex Life Sciences Corp. 

51 West 52nd Street
7th floor
New York  New York  10019  U.S.A.
Phone: 1-844-689-3939 Fax: n/a


Company News
Anavex (AVXL) To Present Interim Phase 2a Clinical Trial Data Of ANAVEX 2-73 At Late-Breaking Oral Session Of CTAD 2015 Conference 10/7/2015 12:55:31 PM
Anavex (AVXL) Prepares For Uplisting To NASDAQ, Announces Reverse Stock Split 10/7/2015 10:06:14 AM
Anavex (AVXL) Completes Patient Enrollment For Phase 2a Alzheimer’s Trial Ahead Of Schedule 9/28/2015 12:20:30 PM
Anavex (AVXL) To Present At 2015 Ladenburg Thalmann Healthcare Conference 9/23/2015 1:47:31 PM
Anavex (AVXL) Appoints International Alzheimer’s Expert To Scientific Advisory Board 9/21/2015 8:39:10 AM
Anavex (AVXL) Reports Fiscal Third Quarter 2015 Financial Results 8/17/2015 10:44:58 AM
Anavex (AVXL) Receives Notice Of Allowance For U.S. Patent Application Related To ANAVEX 2-73 8/12/2015 9:48:08 AM
Anavex (AVXL) Awarded Grant From The Michael J. Fox Foundation For Parkinson’s Research 8/10/2015 10:26:36 AM
Anavex (AVXL) Presents Positive Initial Phase IIa Study Data With ANAVEX 2-73 Showing Early Evidence Of Improving Cognition In Patients With Alzheimer’s Disease At AAIC 2015 7/22/2015 7:10:09 AM
Anavex (AVXL) To Present Initial Clinical Data From The Phase IIa Clinical Trial Of ANAVEX 2-73 At The Alzheimer’s Association International Conference (AAIC) 6/30/2015 7:17:33 AM